Refine
Year of publication
Document Type
- Article (30316)
- Part of Periodical (11874)
- Book (8248)
- Doctoral Thesis (5677)
- Part of a Book (3665)
- Working Paper (3383)
- Review (2878)
- Contribution to a Periodical (2338)
- Preprint (1923)
- Report (1544)
Language
- German (42301)
- English (28834)
- French (1067)
- Portuguese (723)
- Multiple languages (307)
- Croatian (302)
- Spanish (301)
- Italian (194)
- mis (174)
- Turkish (148)
Is part of the Bibliography
- no (74676) (remove)
Keywords
- Deutsch (1038)
- Literatur (807)
- taxonomy (748)
- Deutschland (543)
- Rezension (491)
- new species (443)
- Frankfurt <Main> / Universität (341)
- Rezeption (323)
- Geschichte (292)
- Linguistik (268)
Institute
- Medizin (7636)
- Präsidium (5157)
- Physik (4265)
- Wirtschaftswissenschaften (2679)
- Extern (2661)
- Gesellschaftswissenschaften (2372)
- Biowissenschaften (2168)
- Biochemie und Chemie (1970)
- Center for Financial Studies (CFS) (1620)
- Informatik (1602)
Bbackground: We aimed to investigate the prognostic value of tumour-infiltrating lymphocytes’ (TILs) expression in pretreatment specimens from patients with head and neck squamous cell carcinoma (HNSCC) treated with definitive chemoradiotherapy (CRT).
Methods: The prevalence of CD3+, CD8+, CD4+ and FOXP3+ TILs was assessed using immunohistochemistry in tumour tissue obtained from 101 patients before CRT and was correlated with clinicopathological characteristics as well as local failure-free- (LFFS), distant metastases free- (DMFS), progression-free (PFS) and overall survival (OS). Survival curves were measured using the Kaplan–Meier method, and differences in survival between the groups were estimated using the log-rank test. Prognostic effects of TIL subset density were determined using the Cox regression analysis.
Results: With a mean follow-up of 25 months (range, 2.3–63 months), OS at 2 years was 57.4% for the entire cohort. Patients with high immunohistochemical CD3 and CD8 expression had significantly increased OS (P=0.024 and P=0.028), PFS (P=0.044 and P=0.047) and DMFS (P=0.021 and P=0.026) but not LFFS (P=0.90 and P=0.104) in multivariate analysis that included predictive clinicopathologic factors, such as age, sex, T-stage, N-stage, tumour grading and localisation. Neither CD4 nor FOXP3 expression showed significance for the clinical outcome. The lower N-stage was associated with improved OS in the multivariate analysis (P=0.049).
Conclusion: The positive correlation between a high number of infiltrating CD3+ and CD8+ cells and clinical outcome indicates that TILs may have a beneficial role in HNSCC patients and may serve as a biomarker to identify patients likely to benefit from definitive CRT.